<?xml version="1.0" encoding="UTF-8"?>
<p>The antiviral activity of both compounds against DENV-2 was proven in VERO and LLCMK2 cells treated with caffeoylcalleryanin and verbascoside for 48 h (EC
 <sub>50</sub>: 2.8 ± 0.4 μg/mL, SI: 20.0 and 3.4 ± 0.4 μg/mL, SI: 3.8, respectively) [
 <xref rid="B165-biomolecules-11-00011" ref-type="bibr">165</xref>], but the mechanism of action was not elucidated. However, this kind of catechol compound, such as dicaffeoylquinic acid (DCQA) and related dicaffeoyltartaric acid, 
 <italic>L</italic>-chicoric acid, has been shown to be involved in HIV-RT polymerase inhibition (IC
 <sub>50</sub>: 7–107 µM and 17 µM, respectively), HIV integrase inhibition (IC
 <sub>50</sub>: 7–107 µM and 17 µM, respectively) [
 <xref rid="B166-biomolecules-11-00011" ref-type="bibr">166</xref>], and HCV replication inhibition by 3,5-DCQA (100 µM, 53%) [
 <xref rid="B167-biomolecules-11-00011" ref-type="bibr">167</xref>].
</p>
